Pure Global AI
NCT06256003Recruiting

Assessing Mobile Apps for Adult ADHD

A Randomized, Controlled, Parallel-Group, Intervention Study to Assess At-Home, Digital Therapy for Treating Adult Participants Ages 18-50 Years Old With Attention Deficit Hyperactivity Disorder (ADHD)
Think Now IncorporatedClinicalTrials.govdeviceDevice trial
Verified
Study focus
Disease/Condition
Attention Deficit Hyperactivity Disorder
Drug/Device/Intervention
UC-A
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Think Now Incorporated
Location
Berkeley,Los Angeles, United States of America
Timeline & enrollment
Phase
N/A
Start date
Jan 03, 2024
End date
Oct 01, 2024
Enrollment
140 participants
Primary outcome

Conners Continuous Performance Task (CPT3) - HRT Std (Change from Baseline to Midpoint Mid-treatment, and Baseline to Endpoint Post-treatment)

Summary

The purpose of this clinical trial is to evaluate the effects of mobile app digital therapies
 on cognitive function and symptoms in adults diagnosed with ADHD.

ICD-10 classifications
Neurotic disorder, unspecifiedHyperkinetic disorder, unspecifiedHabit and impulse disorder, unspecifiedMild cognitive disorderDisturbance of activity and attention
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06256003
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06256003 through Pure Global AI's free database. This phase not specified trial is sponsored by Think Now Incorporated and is currently Recruiting. The study focuses on Attention Deficit Hyperactivity Disorder. Target enrollment is 140 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.